End-to-End Optimization of High-Throughput DNA Sequencing.

J Comput Biol

2 Department of Electrical and Computer Engineering, The University of Texas at Austin, Austin, Texas.

Published: October 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

At the core of Illumina's high-throughput DNA sequencing platforms lies a biophysical surface process that results in a random geometry of clusters of homogeneous short DNA fragments typically hundreds of base pairs long-bridge amplification. The statistical properties of this random process and the lengths of the fragments are critical as they affect the information that can be subsequently extracted, that is, density of successfully inferred DNA fragment reads. The ensembles of overlapping DNA fragment reads are then used to computationally reconstruct the much longer target genome sequence. The success of the reconstruction in turn depends on having a sufficiently large ensemble of DNA fragments that are sufficiently long. In this article using stochastic geometry, we model and optimize the end-to-end flow cell synthesis and target genome sequencing process, linking and partially controlling the statistics of the physical processes to the success of the final computational step. Based on a rough calibration of our model, we provide, for the first time, a mathematical framework capturing the salient features of the sequencing platform that serves as a basis for optimizing cost, performance, and/or sensitivity analysis to various parameters.

Download full-text PDF

Source
http://dx.doi.org/10.1089/cmb.2015.0185DOI Listing

Publication Analysis

Top Keywords

high-throughput dna
8
dna sequencing
8
dna fragments
8
dna fragment
8
fragment reads
8
target genome
8
dna
6
end-to-end optimization
4
optimization high-throughput
4
sequencing
4

Similar Publications

The mechanism underlying the effects of Polycyclic aromatic hydrocarbons (PAHs) on missed abortion (MA) remains unclear. This study explored the relationship between PAHs exposure, telomere length (TL), metabolizing enzyme gene polymorphism, and MA in a case-control study with 253 pregnant women. A competitive enzyme-linked immunosorbent assay (ELISA) was used to quantify PAH-DNA adducts.

View Article and Find Full Text PDF

Global efforts to standardise methodologies benefit greatly from open-source procedures that enable the generation of comparable data. Here, we present a modular, high-throughput nucleic acid extraction protocol standardised within the Earth Hologenome Initiative to generate both genomic and microbial metagenomic data from faecal samples of vertebrates. The procedure enables the purification of either RNA and DNA in separate fractions (DREX1) or as total nucleic acids (DREX2).

View Article and Find Full Text PDF

Sequencing of the 16S ribosomal RNA (rRNA) gene is an important tool in addition to conventional methods for the identification of bacterial pathogens in human infections. In polymicrobial samples, Sanger sequencing can produce uninterpretable chromatograms. This limitation can be overcome by Next Generation Sequencing (NGS) of the 16S rRNA gene.

View Article and Find Full Text PDF

Diagnosis of Cytomegalovirus infection in a very low birth weight infant using metagenomic next-generation sequencing: A case report.

Medicine (Baltimore)

September 2025

The Unit of Pathogenic Fungal Infection & Host Immunity, CAS Key Laboratory of Molecular Virology and Immunology, Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai, China.

Rationale: Cytomegalovirus (CMV) is a DNA virus from the herpesvirus family that is widespread among humans. Very low birth weight infants (VLBWI) are particularly susceptible to postnatal CMV infection due to their compromised immune systems. The clinical manifestations of postnatal CMV infection are often nonspecific, which complicates early detection and may lead to multi-organ dysfunction and long-term sequelae.

View Article and Find Full Text PDF

[Glomangiomatosis of uncertain malignant potential: a clinicopathological and genetic analysis].

Zhonghua Bing Li Xue Za Zhi

September 2025

Department of Pathology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China.

To investigate the clinicopathological features, genetic characteristics, and differential diagnosis of glomangiomatosis with uncertain malignant potential. Two cases of glomangiomatosis with uncertain malignant potential were collected at Henan Provincial People's Hospital from 2013 and 2023. Immunohistochemistry and next generation sequencing (DNA-seq) were used to detect the related protein and gene variation.

View Article and Find Full Text PDF